Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05931913 · ClinicalTrials.gov registry record · NA
TMS + Exposure Therapy for Pediatric OCD
A NA study of Obsessive - Compulsive Disorder, sponsored by Bradley Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 2
- Study locations
NCT05931913 is a NA study of Obsessive - Compulsive Disorder that is actively recruiting participants, run by Bradley Hospital. The registered enrollment target is 60 participants, below the 2,064-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT05931913, a NA study of Obsessive - Compulsive Disorder, is actively recruiting participants, sponsored by Bradley Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this clinical trial is to compare different forms of transcranial magnetic stimulation (TMS) for improving the outcomes of Exposure with Response Prevention (ERP) in youth and young adults with Obsessive-Compulsive Disorder (OCD). Researchers will compare three groups: ERP with one of two different active ("real") forms of TMS vs. ERP with sham ("fake") TMS. The main questions this study aims to answer are: 1) whether TMS normalizes functioning in brain circuits that contribute to compulsive behavior, and 2) whether TMS reduces compulsions during ERP. Participants will: * Complete clinical interviews, questionnaires, and computerized tasks * Complete two MRIs (brain scans) * Receive daily TMS followed by ERP for two weeks (10 sessions)
Conditions Studied
Interventions
- DEVICE Transcranial Magnetic Stimulation: intermittent theta burst to dorsolateral prefrontal cortex
- BEHAVIORAL Exposure with Response Prevention
- DEVICE Transcranial Magnetic Stimulation: Sham
- DEVICE Transcranial Magnetic Stimulation: continuous theta burst to pre supplementary motor area
Study Locations (2)
Minnesota
- University of Minnesota - Minneapolis
Rhode Island
- Emma Pendleton Bradley Hospital - Riverside
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-03-20 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05931913
The ClinicalTrials.gov registry entry for NCT05931913 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,064-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (97% lower). The listed sponsor is Bradley Hospital, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Obsessive - Compulsive Disorder appearing as the primary indexed condition, and to 4 interventions - of which Transcranial Magnetic Stimulation: intermittent theta burst to dorsolateral prefrontal cortex is the first listed.
NCT05931913 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Minnesota, Rhode Island.
Frequently Asked Questions
What is clinical trial NCT05931913 about?
NCT05931913 is a clinical study titled "TMS + Exposure Therapy for Pediatric OCD". The goal of this clinical trial is to compare different forms of transcranial magnetic stimulation (TMS) for improving the outcomes of Exposure with Response Prevention (ERP) in youth and young adults with Obsessive-Compulsive Disorder (OCD). Researchers will compare three groups: ERP with one of tw...
What is the current status of trial NCT05931913?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-03-20. Estimated completion is 2026-07-31.
What conditions does trial NCT05931913 study?
This clinical trial studies the following conditions: Obsessive - Compulsive Disorder.
What interventions are being tested in trial NCT05931913?
The interventions under investigation include: Transcranial Magnetic Stimulation: intermittent theta burst to dorsolateral prefrontal cortex (DEVICE), Exposure with Response Prevention (BEHAVIORAL), Transcranial Magnetic Stimulation: Sham (DEVICE), Transcranial Magnetic Stimulation: continuous theta burst to pre supplementary motor area (DEVICE).
Who is sponsoring clinical trial NCT05931913?
This trial is sponsored by Bradley Hospital, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05931913 being conducted?
This trial has 2 study locations across Minnesota, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obsessive - Compulsive Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Transcranial Magnetic Stimulation and Psychotherapy for Treating Obsessive-Compulsive Disorder
RECRUITING · NA
-
Mechanisms of Exposure Therapy for OCD
RECRUITING · NA
-
Using Personalized Assessments in the Treatment of Childhood OCD
RECRUITING · NA
-
Neural Mechanisms of Response Inhibition Training for OCRD
RECRUITING · NA
-
CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy
RECRUITING · NA
-
Interpretation Bias as a Mechanism of Treatment Response in OCD
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.